Merck Serono's Erbitux(R) Cited As 'One Of The Most Significant Advances In The Last 25 Years' In The Treatment Of ... (Medical News Today)
Merck Serono, a division of Merck KGaA of Germany, has won a Frost & Sullivan Customer Value Enhancement (CVE) Award for its epidermal growth factor r...
Original post: Merck Serono's Erbitux(R) Cited As 'One Of The Most Significant Advances In The Last 25 Years' In The Treatment Of ... (Medical News Today) by Copyright (c) 2004 Yahoo! Inc. All rights reserved. at Yahoo! News Search Results for glucophage